Found: 10
Select item for more details and to access through your institution.
A Common Genomic Framework for a Diverse Assembly of Plasmids in the Symbiotic Nitrogen Fixing Bacteria.
- Published in:
- PLoS ONE, 2008, v. 3, n. 7, p. 1, doi. 10.1371/journal.pone.0002567
- By:
- Publication type:
- Article
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-09799-2
- By:
- Publication type:
- Article
Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer.
- Published in:
- Breast Cancer Research, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13058-015-0532-0
- By:
- Publication type:
- Article
Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Identification of chemokine receptors as potential modulators of endocrine resistance in estrogen receptor positive breast cancers.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 5, p. 1, doi. 10.1186/s13058-014-0447-1
- By:
- Publication type:
- Article
Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor-positive breast cancers.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo.
- Published in:
- Breast Cancer Research, 2012, v. 14, n. 5, p. 3330, doi. 10.1186/bcr3330
- By:
- Publication type:
- Article
Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article
ESR1 Is Co-Expressed with Closely Adjacent Uncharacterised Genes Spanning a Breast Cancer Susceptibility Locus at 6q25.1.
- Published in:
- PLoS Genetics, 2011, v. 7, n. 4, p. 1, doi. 10.1371/journal.pgen.1001382
- By:
- Publication type:
- Article